2014
DOI: 10.3389/fphar.2014.00197
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative acute hypertension—role of Clevidipine butyrate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 49 publications
(60 reference statements)
0
3
0
Order By: Relevance
“…Various modulators can potentiate or block calcium entry through L-type calcium channels. [4][5][6] Calcium antagonists have a versatile pharmacological activity such as antihypertensive and antianginal, [7][8][9] antitumor, 10,11) anti-inflammatory, 12,13) antitubercular, 14,15) anticonvulsant and antithrombotic. 16,17) 1,4-DHPs bind selectively to L-type calcium channel protein, precisely at the transmembrane domain IIIS6 and IVS6 regions of the α1 subunit.…”
mentioning
confidence: 99%
“…Various modulators can potentiate or block calcium entry through L-type calcium channels. [4][5][6] Calcium antagonists have a versatile pharmacological activity such as antihypertensive and antianginal, [7][8][9] antitumor, 10,11) anti-inflammatory, 12,13) antitubercular, 14,15) anticonvulsant and antithrombotic. 16,17) 1,4-DHPs bind selectively to L-type calcium channel protein, precisely at the transmembrane domain IIIS6 and IVS6 regions of the α1 subunit.…”
mentioning
confidence: 99%
“…Hypertensive emergencies usually require the intravenous administration of antihypertensive drugs ( Kurnutala et al, 2014 ). Esmolol is a super short-acting selective beta antagonist.…”
Section: Discussionmentioning
confidence: 99%
“…CaV1.2 blockers can be roughly categorized into three different chemical classes: 3,4-dihydropyrimidine-2-one (DHP) derivatives, phenylalkylamine derivatives and benzothiazepine derivatives. Calcium antagonists have a versatile pharmacological activity such as antihypertensive and antianginal, antitumor, anti-inflammatory, antitubercular, anticonvulsant and antithrombotic [9][10][11][12][13][14][15][16][17][18][19]. The target key intermediate 3,4-dihydropyrimidine-2-one was synthesized according to the reported procedure.…”
Section: Pyrimidine Ringmentioning
confidence: 99%